Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.

Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.

Item
http://www.wikidata.org/entity/Q33607108
Checkpoint Blockade Toxicity and Immune Homeostasis in the Gastrointestinal Tract.Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Resolution of Infliximab-Refractory Nivolumab-Induced Acute Severe Enterocolitis After Cyclosporine Treatment in a Patient with Non-Small Cell Lung Cancer.Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab.Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice.Emerging Role of Vedolizumab in Managing Refractory Immune Checkpoint Inhibitor-Induced Enteritis.A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report.Anti-Inflammatory Biologics and Anti-Tumoral Immune Therapies-Associated Colitis: A Focused Review of Literature.Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: focusing on non-small cell lung cancer patients.The Effect of TNF and VEGF on the Properties of Ea.hy926 Endothelial Cells in a Model of Multi-Cellular Spheroids.Identifying and managing the adverse effects of immune checkpoint blockade.Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitisImmune Checkpoint Inhibitor-Associated Colits and Hepatitis
P2860

Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.

Item
http://www.wikidata.org/entity/Q33607108
description
2017 nî lūn-bûn
@nan
2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.
@ast
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.
@en
type
label
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.
@ast
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.
@en
prefLabel
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.
@ast
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P932
P356
P1433
P1476
Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P932